LGN vs XLV
Legence Corp. Class A Common stock (LGN) versus Health Care Select Sector SPDR® Fund (XLV) — a side-by-side from cached financials, not a winner call.
Legence Corp. Class A Common stock (LGN) is a engineering & construction company listed on NASDAQ.
Health Care Select Sector SPDR® Fund (XLV) common stock listed on US.
Latest reported LGN revenue for 2025-12-31 was $2.55B. Net income was -$59.8M. Revenue was up 21.5% from 2024-12-31 to 2025-12-31. LGN currently screens at market cap $14.66B.
XLV does not have a complete income-statement cache yet.
LGN currently screens at market cap $14.66B. XLV currently screens at market cap $0.
Not investment advice. Open the LGN and XLV stock pages for the full models.
Not investment advice.